Parma J, Duprez L, Van Sande J, Hermans J, Rocmans P, Van Vliet G, Costagliola S, Rodien P, Dumont J E, Vassart G
Department of Medical Genetics, Université Libre de Bruxelles, Belgium.
J Clin Endocrinol Metab. 1997 Aug;82(8):2695-701. doi: 10.1210/jcem.82.8.4144.
A total of 33 different autonomous hot nodules from 31 patients, originating mainly from Belgium, were investigated for the presence of somatic mutations in the TSH receptor and Gs alpha genes. This constitutes an extension of our previous study, including the first 11 nodules of the series. The complete coding sequence of the TSH receptor gene and the segments of Gs alpha known to harbor mutations impairing guanosinetriphosphotase activity were studied by direct sequencing of genomic DNA extracted from the nodules. DNA from the juxtanodular tissue or peripheral white blood cells was analyzed in all patients to confirm that the mutations identified were somatic. Twenty-seven mutations (82%) were found in the TSH receptor gene, affecting a total of 12 different residues or locations. All these mutations but 2 (see below) have been identified previously as activating mutations. Only 2 mutations were found in Gs alpha (6%). In 4 nodules, no mutation was detected. Five residues (Ser281, Ile486, Ile568, Phe631, and Asp633) were found mutated in 3 or 4 different nodules, making them hot spots for activating mutations. Phe631 and Asp633 belong to a cluster of 5 consecutive residues (629-633) in the N-terminal half of transmembrane segment VI; which harbor together 44% of the mutations identified in this cohort. Two novel mutations were identified: a point mutation causing substitution of Phe for Leu at position 629 (L629F); and a deletion of 12 bases removing residues 658-661 at the C-terminal portion of exoloop 3 (del658-661). When tested by transfection in COS-7 cells, both mutant receptors display increase in constitutive stimulation of basal cAMP accumulation. Although it is still capable of binding TSH, the del658-661 mutant has completely lost the ability to respond to the stimulation by the hormone. Our results demonstrate that, in a cohort of patients from a moderately iodine deficient area, somatic mutations increasing the constitutive activity of the TSH receptor are the major cause of autonomous hot nodules.
对来自31名患者的总共33个不同的自主性热结节进行了研究,这些患者主要来自比利时,研究目的是检测促甲状腺激素(TSH)受体基因和Gsα基因中的体细胞突变。这是我们先前研究的扩展,包括该系列的前11个结节。通过对从结节中提取的基因组DNA进行直接测序,研究了TSH受体基因的完整编码序列以及已知携带损害鸟苷三磷酸酶活性突变的Gsα片段。对所有患者的结节旁组织或外周血白细胞的DNA进行分析,以确认所鉴定的突变是体细胞突变。在TSH受体基因中发现了27个突变(82%),共影响12个不同的残基或位置。除2个突变外(见下文),所有这些突变先前均被鉴定为激活突变。在Gsα中仅发现2个突变(6%)。在4个结节中未检测到突变。发现5个残基(Ser281、Ile486、Ile568、Phe631和Asp633)在3个或4个不同的结节中发生突变,使其成为激活突变的热点。Phe631和Asp633属于跨膜片段VI N端一半中5个连续残基(629 - 633)的簇;该簇共包含该队列中鉴定出的44%的突变。鉴定出两个新突变:一个点突变导致629位的苯丙氨酸被亮氨酸取代(L629F);以及一个12个碱基的缺失,去除了外环3 C端部分的658 - 661位残基(del658 - 661)。当在COS - 7细胞中进行转染测试时,两种突变受体在基础环磷酸腺苷(cAMP)积累的组成性刺激方面均表现出增加。尽管del658 - 661突变体仍能够结合TSH,但它已完全丧失了对该激素刺激作出反应的能力。我们的结果表明,在来自碘中度缺乏地区的一组患者中,增加TSH受体组成性活性的体细胞突变是自主性热结节的主要原因。